Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02294487 · ClinicalTrials.gov registry record
Study of the Immune Response After Vaccination in Multiple Myeloma Patients
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 19
- Enrollment target
NCT02294487 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 19 participants.
The verdict
NCT02294487 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
This study will collect blood samples from healthy volunteers and volunteers with multiple myeloma who are going to get the seasonal flu, pneumonia, haemophilus influenzae B (HIB), and/or meningococcus vaccines. The main goal of the study is to start to identify differences in the immune response between multiple myeloma patients and people who don't have multiple myeloma. We hope this will provide important information about the best way and time to vaccinate multiple myeloma patients to flu, pneumonia, haemophilus influenzae B (HIB), and/or meningococcus .
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2014-12-30 |
| Est. Completion | 2017-08-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02294487
The ClinicalTrials.gov registry entry for NCT02294487 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02294487 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02294487 about?
NCT02294487 is a clinical study titled "Study of the Immune Response After Vaccination in Multiple Myeloma Patients". This study will collect blood samples from healthy volunteers and volunteers with multiple myeloma who are going to get the seasonal flu, pneumonia, haemophilus influenzae B (HIB), and/or meningococcus vaccines. The main goal of the study is to start to identify differences in the immune response b...
What is the current status of trial NCT02294487?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2014-12-30. Estimated completion is 2017-08-10.
Who is sponsoring clinical trial NCT02294487?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.